← All organizations
Highest phase reached
Phase 1
First clinical trial
Oct 9, 2017Last known activity
Oct 9, 2017
Timeline
2010s
- Jun 1, 2015
ImmunoMet Therapeutics, Inc.— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (1)
- NCT03272256Lead sponsorPhase 1Oct 9, 2017
Details
- Founded
- Houston, TX, US Jun 1, 2015
- Last known activity
- Oct 9, 2017